Atencion primaria · 2026
[Diabetic neuropathy and its relationship with quality of life in patients with type 2 diabetes].
СтатьяНаблюдательное исследованиеАннотация на английскомНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Arévalo Ramírez Jarek Ramón, Castañón Sánchez Daniela Leticia, Vargas Ordoñez Oscar Isaías, Camarena Velázquez Hilda Sara, Aguirre García María Del Carmen, Osorio Granjeno Mónica Catalina
Аннотация
OBJECTIVE: To determine the association between diabetic neuropathy (DN) and quality of life (QoL) in patients with type 2 diabetes mellitus (DM2).
SETTING: Family Medicine Unit No. 33 (UMF 33), El Rosario, Azcapotzalco, Mexico City, Mexico.
DESIGN: Observational, analytical, cross-sectional.
PARTICIPANTS: 365 participants aged 18 years or older with a diagnosis of DM2, ascribed to a specialized diabetes care program.
MEASUREMENTS: A sociodemographic questionnaire and two standardized instruments were applied: the Michigan Neuropathy Screening Instrument (MNSI), in its questionnaire (MNSIQ) and physical examination (MNSIEF) components and the SF-12v2 questionnaire to assess QoL through its physical (PCS) and mental (MCS) components. Frequencies and percentages were analyzed. The chi-square test was used for inferential statistics.
RESULTS: According to the MNSIQ, 35.6% presented signs of ND, while the MNSIEF it was detected in 99.2% of the participants. 59.5% reported good physical QoL, while 61.4% reported poor mental QoL. Although descriptive differences were notable, the statistical power was limited to demonstrate consistent associations between ND and QoL.
CONCLUSIONS: The findings suggest a discordance between patient self-perception and physical examination. ND could have a negative impact on QoL, especially on the mental component (MCS). Active screening for ND in primary care settings may enhance comprehensive care and improve perceived well-being in people with DM2.
SETTING: Family Medicine Unit No. 33 (UMF 33), El Rosario, Azcapotzalco, Mexico City, Mexico.
DESIGN: Observational, analytical, cross-sectional.
PARTICIPANTS: 365 participants aged 18 years or older with a diagnosis of DM2, ascribed to a specialized diabetes care program.
MEASUREMENTS: A sociodemographic questionnaire and two standardized instruments were applied: the Michigan Neuropathy Screening Instrument (MNSI), in its questionnaire (MNSIQ) and physical examination (MNSIEF) components and the SF-12v2 questionnaire to assess QoL through its physical (PCS) and mental (MCS) components. Frequencies and percentages were analyzed. The chi-square test was used for inferential statistics.
RESULTS: According to the MNSIQ, 35.6% presented signs of ND, while the MNSIEF it was detected in 99.2% of the participants. 59.5% reported good physical QoL, while 61.4% reported poor mental QoL. Although descriptive differences were notable, the statistical power was limited to demonstrate consistent associations between ND and QoL.
CONCLUSIONS: The findings suggest a discordance between patient self-perception and physical examination. ND could have a negative impact on QoL, especially on the mental component (MCS). Active screening for ND in primary care settings may enhance comprehensive care and improve perceived well-being in people with DM2.